Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Miró, J M; García-de-la-Mària, C; Armero, Y; Soy, D; Moreno, A; del Río, A; Almela, M; Sarasa, M; Mestres, C A; Gatell, J M; Jiménez de Anta, M T; Marco, F

Miró, J M; García-de-la-Mària, C; Armero, Y; Soy, D; Moreno, A; del Río, A; Almela, M; Sarasa, M; Mestres, C A; Gatell, J M; Jiménez de Anta, M T; Marco, F.

Affiliation

Miró JM; Infectious Diseases Service, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain. jmmiro@ub.edu

Antimicrob Agents Chemother ; 53(10): 4172-7, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19620326

Subject(s)

Anti-Bacterial Agents/therapeutic use; Daptomycin/therapeutic use; Gentamicins/therapeutic use; Methicillin-Resistant Staphylococcus aureus/pathogenicity; Animals; Endocarditis, Bacterial/drug therapy; Endocarditis, Bacterial/microbiology; Humans; Methicillin-Resistant Staphylococcus aureus/drug effects; Microbial Sensitivity Tests; Rabbits

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gentamicins / Daptomycin / Methicillin-Resistant Staphylococcus aureus / Anti-Bacterial Agents Limits: Animals / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2009 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google